Helen Thackray

Director/Board Member at EUPRAXIA PHARMACEUTICALS INC.

Net worth: 1 M $ as of 31/07/2026

57 year

60 connections

Health Technology

Consumer Services

Health Services

Profile

Helen M.
Thackray is currently Director at Eupraxia Pharmaceuticals, Inc. since 2026, Member of the Institutional Review Board at Holy Cross Hospital (Maryland), and Assistant Clinical Professor at GW School of Medicine & Health Sciences since 2000.
Former positions include Independent Director at ImmunoGen, Inc. from 2021 to 2024, Chief Research & Development Officer at BioCryst Pharmaceuticals, Inc. from 2021 to 2025, Vice President-Clinical Product Development at Biosynexus, Inc. from 2001 to 2006, Chief Medical Officer & SVP-Clinical Development at GlycoMimetics, Inc. from 2012 to 2021, and Member of the Institutional Review Board at the National Center for Health Statistics.
Education includes undergraduate studies at Stanford University and a doctorate from GW School of Medicine & Health Sciences.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
BIOCRYST PHARMACEUTICALS, INC. 0.06%	13/04/2026	161,618 ( 0.06% )	1 M $	31/07/2026
EUPRAXIA PHARMACEUTICALS, INC. -.--%	13/07/2026	0 ( -.--% )	- $	31/07/2026

Helen Thackray active positions

Companies	Position	Start
EUPRAXIA PHARMACEUTICALS INC.	Director/Board Member	07/07/2026
Holy Cross Hospital (Maryland)	Corporate Officer/Principal	-
Gw School of Medicine & Health Sciences Gw School of Medicine & Health Sciences Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	01/01/2000

All active positions of Helen Thackray

Former positions of Helen Thackray

Companies	Position	End
BIOCRYST PHARMACEUTICALS, INC.	Chief Tech/Sci/R&D Officer	01/09/2025
IMMUNOGEN, INC.	Director/Board Member	12/02/2024
GlycoMimetics, Inc. GlycoMimetics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat inflammatory diseases and cancer	Chief Tech/Sci/R&D Officer	19/03/2021
Biosynexus, Inc. Biosynexus, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products	Corporate Officer/Principal	01/01/2006
National Center for Health Statistics National Center for Health Statistics General GovernmentGovernment Provides public health statistics	Corporate Officer/Principal	-

See the detail of Helen Thackray's experience

Training of Helen Thackray

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Helen Thackray's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	9
BioCryst Pharmaceuticals, Inc. BioCryst Pharmaceuticals, Inc. BiotechnologyHealth Technology Designs and develops oral small-molecule & injectable protein therapeutics	Health Technology
ImmunoGen, Inc. ImmunoGen, Inc. BiotechnologyHealth Technology Develops anticancer therapeutics	Health Technology
Eupraxia Pharmaceuticals, Inc. Eupraxia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on the development of delivered, extended-release alternatives to currently approved drugs	Health Technology
Stanford University Stanford University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Biosynexus, Inc. Biosynexus, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products	Health Technology
GlycoMimetics, Inc. GlycoMimetics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat inflammatory diseases and cancer	Health Technology
Holy Cross Hospital (Maryland)	Health Services
National Center for Health Statistics National Center for Health Statistics General GovernmentGovernment Provides public health statistics	Government
Gw School of Medicine & Health Sciences Gw School of Medicine & Health Sciences Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services